IMUX Immunic, Inc. - Common Stock
$17,04
Prix · Aoû 19, 2026
Données fondamentales au Aoû 11, 2026
Fourchette 52 semaines
$1–$17
98% of range
Note des analystes
BUY
16 analysts
Objectif de cours
$42
+148% upside
P/E (TTM)
-0.9
ROE
—
Marge nette
—
IMUX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$17.04
Capitalisation Boursière
—
P/E (TTM)
-0.9
BPA (TTM)
$-0.62
Revenus (TTM)
—
Rendement div.
—
ROE
—
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $17
IMUX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
BPA
$-0.62
2020-12-31
→
2025-12-31
Flux de trésorerie libre
—
2016-12-31
→
2024-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
IMUX
Médiane des pairs
P/E (TTM)
-0.9
1.2
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
IMUX
Médiane des pairs
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
IMUX
Médiane des pairs
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
IMUX
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
IMUX
Médiane des pairs
IMUX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
16 analystes
- Achat fort 7 43,8%
- Achat 8 50,0%
- Conserver 1 6,2%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
11 analystes · 2026-08-19
Médiane
$30.00
Moyenne
$42.18
← En dessous de tous les objectifs
$17.04
Bas
$19.00
Haut
$85.00
Objectif médian
$30.00
+76,1%
Objectif moyen
$42.18
+147,6%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.04%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-1.08 | $-0.93 | -0.15% |
| 31 décembre 2025 | $-0.70 | $-0.96 | 0.26% |
| 30 septembre 2025 | $-1.30 | $-1.71 | 0.41% |
| 30 juin 2025 | $-2.00 | $-1.68 | -0.32% |
| 31 mars 2025 | $-0.25 | $-0.24 | -0.01% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| IMUX | — | -0.9 | — | — | — | — |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| CNXU | — | — | — | — | — | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| NBP | — | — | — | — | — | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $82M | $80M | $83M | $71M | $61M | $39M | $23M | $10M | $39M | $30M | $40M | $39M | |
| SG&A Expense | $21M | $18M | $16M | $15M | $13M | $10M | $15M | $2M | $13M | $11M | $12M | $11M | |
| Operating Expenses | $103M | $98M | $99M | $119M | $92M | $49M | $37M | $12M | $53M | $41M | $52M | $50M | |
| Operating Income | $-103M | $-98M | $-99M | $-119M | $-92M | $-49M | $-37M | $-12M | $-53M | $-41M | $-52M | $-50M | |
| Interest Income | $1M | $3M | $3M | $1M | $66.0K | $58.0K | $107.0K | $521.0K | $650.0K | $284.0K | $58.0K | $19.0K | |
| Other Non-op | $5M | $-1M | $3M | $-2M | $-1M | $5M | $2M | $456.0K | $-73.0K | $13.0K | $39.0K | $56.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-41M | $-52M | $-41M | $-52M | $-48M | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-97M | $-101M | $-94M | $-120M | $-93M | $-44M | $-35M | $-12M | $-52M | $-41M | $-52M | $-48M | |
| EPS (Basic) | $-0.62 | $-1.00 | $-2.11 | $-3.78 | $-3.93 | $-2.81 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.62 | $-1.00 | $-2.11 | $-3.78 | $-3.93 | $-2.81 | · | · | · | · | · | · | |
| Shares (Basic) | 155,688,030 | 100,174,766 | 44,320,050 | 31,819,006 | 23,652,779 | 15,663,826 | · | · | · | · | · | · | |
| Shares (Diluted) | 155,688,030 | 100,174,766 | 44,320,050 | 31,819,006 | 23,652,779 | 15,663,826 | · | · | · | · | · | · | |
| EBITDA | · | $-98M | $-99M | $-119M | $-92M | $-49M | $-37M | $-41M | · | $-39M | $-51M | $-49M |
Bilan 23
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $36M | $47M | $107M | $87M | $127M | $29M | $13M | $57M | $60M | $83M | $102M | |
| Prepaid Expense | $7M | $4M | $6M | $9M | $18M | $6M | $3M | $259.0K | $1M | $1M | $1M | $986.0K | |
| Other Current Assets | $831.0K | $1M | $1M | $1M | $1M | $1M | $796.0K | $68.0K | · | · | · | · | |
| Current Assets | $23M | $39M | $53M | $126M | $105M | $134M | $32M | $13M | $58M | $61M | $85M | $105M | |
| PP&E (Net) | $608.0K | $545.0K | $466.0K | $294.0K | $152.0K | $203.0K | $80.0K | $40.0K | $2M | $3M | $4M | $3M | |
| PP&E (Gross) | · | · | · | · | · | · | · | $11M | $12M | $12M | $12M | $10M | |
| Accum. Depreciation | · | · | · | · | · | · | · | $11M | $10M | $10M | $8M | $7M | |
| Goodwill | · | · | · | $0 | $33M | $33M | $33M | $0 | · | · | · | · | |
| Other Non-current Assets | · | · | $0 | $43.0K | $42.0K | $42.0K | $42.0K | $0 | $108.0K | $58.0K | $184.0K | $198.0K | |
| Total Assets | $24M | $41M | $54M | $128M | $139M | $168M | $66M | $13M | $60M | $64M | $89M | $108M | |
| Accounts Payable | $10M | $8M | $5M | $4M | $4M | $4M | $2M | $1M | $1M | $780.0K | $1M | $1M | |
| Accrued Liabilities | $19M | $13M | $19M | $8M | $7M | $4M | $3M | $416.0K | $9M | $5M | $5M | $9M | |
| Current Liabilities | $31M | $22M | $25M | $13M | $11M | $8M | $7M | $2M | $10M | $5M | $7M | $10M | |
| Capital Leases | $107.0K | $264.0K | $639.0K | $992.0K | $584.0K | $679.0K | $520.0K | $41.0K | $59.0K | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | · | $99.0K | $101.0K | $241.0K | |
| Total Liabilities | $31M | $22M | $25M | $14M | $12M | $9M | $8M | $2M | · | · | · | · | |
| Common Stock | $9.0K | $8.0K | $4.0K | $4.0K | $3.0K | $2.0K | $1.0K | $0 | $4.0K | $3.0K | $3.0K | $2.0K | |
| Paid-in Capital | $599M | $526M | $436M | $428M | $324M | $267M | $120M | $56.0K | $346M | $302M | $285M | $248M | |
| Retained Earnings | $-609M | $-511M | $-411M | $-317M | $-197M | $-104M | $-60M | $-25M | $-296M | $-244M | $-203M | $-151M | |
| AOCI | $3M | $4M | $4M | $3M | $-252.0K | $-4M | $-1M | $-819.0K | $78.0K | $83.0K | $80.0K | $89.0K | |
| Stockholders' Equity | $-7M | $18M | $29M | $114M | $127M | $159M | $58M | $-26M | $-13M | $58M | $82M | $98M | |
| Liabilities + Equity | $24M | $41M | $54M | $128M | $139M | $168M | $66M | $13M | $60M | $64M | $89M | $108M | |
| Shares Outstanding | 12,038,263 | 9,015,087 | 45,177,730 | 39,307,286 | 26,335,418 | 21,168,240 | 10,744,806 | 846,953 | 42,368,864 | 32,143,475 | 30,473,083 | 23,982,786 |
Flux de trésorerie 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168.0K | $134.0K | $111.0K | $77.0K | $85.0K | $39.0K | $50.0K | $15.0K | $998.0K | $2M | $1M | $1M | |
| Stock-based Comp | $9M | $9M | $7M | $8M | $6M | $3M | $7M | $0 | $5M | $5M | $4M | $3M | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | · | $7M | $16M | $47M | $4M | $-5M | $-174.0K | $-6M | · | $-1M | $-3M | $3M | |
| Operating Cash Flow | $-86M | $-85M | $-71M | $-65M | $-83M | $-46M | $-29M | $-10M | $-40M | $-36M | $-50M | $-41M | |
| CapEx | $161.0K | $264.0K | $334.0K | $112.0K | $67.0K | $146.0K | $55.0K | $32.0K | $685.0K | $556.0K | $2M | $1M | |
| Investing Cash Flow | $-161.0K | $-264.0K | $9M | $-10M | $-67.0K | $-146.0K | $11M | $-32.0K | $-678.0K | $-21.0K | · | · | |
| Stock Issued | $0 | $191.0K | $853.0K | · | · | · | $0 | $19M | $38M | $12M | $32M | $88M | |
| Net Stock Activity | · | $191.0K | · | · | · | · | $0 | $0 | · | $12M | $32M | $88M | |
| Financing Cash Flow | $66M | $75M | $1M | $96M | $43M | $144M | $35M | $19M | $38M | $12M | · | · | |
| Net Change in Cash | $-20M | $-11M | $-60M | $20M | $-41M | $98M | $16M | $9M | $-3M | $-23M | $-19M | $64M | |
| Free Cash Flow | · | $-85M | $-71M | $-65M | $-83M | $-46M | $-29M | $-44M | · | $-36M | $-52M | $-42M |
Rentabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -211.2% | -102.8% | -90.2% | -60.6% | -37.6% | -88.1% | -110.1% | · | -53.5% | -52.8% | -61.6% | |
| ROE | · | -337.0% | -242.1% | -108.2% | -68.2% | -27.4% | -58.8% | 990.7% | · | -58.2% | -57.8% | -180.2% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.8 | 2.1 | 9.6 | 9.2 | 15.9 | 4.6 | 5.7 | · | 11.2 | 12.8 | 10.2 | |
| Quick Ratio | · | 1.6 | 1.9 | 8.2 | 7.6 | 15.2 | 4.2 | 5.3 | · | 10.9 | 12.5 | 9.9 |
Valorisation (TTM) 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-97M | $-101M | $-94M | $-120M | $-93M | $-44M | $-35M | $-12M | $-52M | $-41M | $-52M | $-48M | |
| Market Cap | · | $90M | $68M | $55M | $252M | $324M | $104M | $315M | · | $5.59B | $14.04B | $23.92B | |
| P/E | -0.9 | -1.0 | -0.7 | -0.4 | -2.4 | -5.4 | · | · | · | · | · | · | |
| P/B | · | 4.9 | 2.3 | 0.5 | 2.0 | 2.0 | 1.8 | 25.4 | · | 95.7 | 170.6 | 245.1 | |
| P / Tangible Book | · | 4.9 | 2.3 | 0.5 | 2.7 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | · | -1.1 | -1.0 | -0.8 | -3.0 | -7.0 | -3.7 | -7.3 | · | -156.3 | -281.1 | -585.8 | |
| P / FCF | · | -1.1 | -1.0 | -0.8 | -3.0 | -7.0 | -3.6 | -7.2 | · | -153.9 | -268.5 | -566.3 | |
| Earnings Yield | -116.1% | -100.0% | -140.7% | -270.0% | -41.1% | -18.4% | · | · | · | · | · | · |
Compte de résultat 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $26M | $26M | $19M | $20M | $21M | $22M | $22M | $21M | $18M | $19M | $19M | $20M | $21M | $23M | $21M | $17M | |
| SG&A Expense | $9M | $8M | $4M | $6M | $6M | $5M | $4M | $4M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $35M | $33M | $23M | $26M | $27M | $27M | $26M | $26M | $23M | $24M | $23M | $24M | $25M | $27M | $57M | $20M | |
| Operating Income | $-35M | $-33M | $-23M | $-26M | $-27M | $-27M | $-26M | $-26M | $-23M | $-24M | $-23M | $-24M | $-25M | $-27M | $-57M | $-20M | |
| Interest Income | $1M | $760.0K | $197.0K | $419.0K | $241.0K | $183.0K | $429.0K | $776.0K | $998.0K | $1M | $541.0K | $766.0K | $968.0K | $800.0K | $698.0K | $230.0K | |
| Other Non-op | $-58.0K | $-113.0K | $4M | $-5.0K | $22.0K | $1M | $27.0K | $582.0K | $436.0K | $-2M | $1M | $35.0K | $54.0K | $1M | $155.0K | $-1M | |
| Net Income | $-34M | $-33M | $-19M | $-26M | $-27M | $-25M | $-25M | $-24M | $-21M | $-30M | $-22M | $-23M | $-24M | $-25M | $-56M | $-21M | |
| EPS (Basic) | $-0.80 | $-1.08 | $-0.04 | $-0.13 | $-2.03 | $-2.51 | $-0.25 | $-0.24 | $-0.21 | $-0.30 | $-0.48 | $-0.51 | $-0.54 | $-0.58 | $-1.63 | $-0.69 | |
| EPS (Diluted) | $-0.80 | $-1.08 | $-0.04 | $-0.13 | $-2.03 | $-2.51 | $-0.25 | $-0.24 | $-0.21 | $-0.30 | $-0.48 | $-0.51 | $-0.54 | $-0.58 | $-1.63 | $-0.69 | |
| Shares (Basic) | 42,513,839 | 30,136,324 | -271,729,369 | 193,897,764 | 13,217,520 | 10,134,443 | -199,670,349 | 101,272,580 | 101,272,580 | 97,299,955 | -88,352,065 | 44,574,377 | 44,432,955 | 43,664,783 | -57,122,044 | 30,564,995 | |
| Shares (Diluted) | 42,513,839 | 30,136,324 | -271,729,369 | 193,897,764 | 13,217,520 | 10,134,443 | -199,670,349 | 101,272,580 | 101,272,580 | 97,299,955 | -88,352,065 | 44,574,377 | 44,432,955 | 43,664,783 | -57,122,044 | 30,564,995 | |
| EBITDA | $-35M | $-33M | · | $-26M | $-27M | $-27M | · | $-26M | $-23M | $-24M | · | $-24M | $-25M | $-27M | · | $-20M |
Bilan 20
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $155M | $187M | $15M | $35M | $55M | $14M | $36M | $59M | $80M | $97M | $47M | $60M | $77M | $93M | $107M | $73M | |
| Prepaid Expense | $3M | $2M | $7M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $6M | $6M | $9M | $9M | $9M | $14M | |
| Other Current Assets | $850.0K | $1M | $1M | $818.0K | $861.0K | $1M | $1M | $757.0K | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $2M | |
| Current Assets | $158M | $189M | $23M | $39M | $60M | $19M | $39M | $63M | $85M | $103M | $53M | $65M | $87M | $107M | $126M | $87M | |
| PP&E (Net) | $771.0K | $566.0K | $608.0K | $640.0K | $612.0K | $572.0K | $545.0K | $618.0K | $585.0K | $442.0K | $466.0K | $288.0K | $290.0K | $288.0K | $294.0K | $159.0K | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $33M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $43.0K | $43.0K | $43.0K | $43.0K | $42.0K | |
| Total Assets | $159M | $190M | $24M | $41M | $61M | $21M | $41M | $65M | $86M | $104M | $54M | $67M | $89M | $109M | $128M | $121M | |
| Accounts Payable | $13M | $11M | $10M | $8M | $8M | $6M | $8M | $6M | $8M | $7M | $5M | $3M | $5M | $5M | $4M | $4M | |
| Accrued Liabilities | $18M | $22M | $19M | $19M | $18M | $18M | $13M | $16M | $14M | $12M | $19M | $14M | $13M | $10M | $8M | $7M | |
| Current Liabilities | $31M | $38M | $31M | $30M | $27M | $26M | $22M | $23M | $23M | $20M | $25M | $18M | $18M | $16M | $13M | $12M | |
| Capital Leases | $328.0K | $146.0K | $107.0K | $126.0K | $205.0K | $210.0K | $264.0K | $186.0K | $241.0K | $433.0K | $639.0K | $789.0K | $1M | $1M | $992.0K | $759.0K | |
| Total Liabilities | $32M | $39M | $31M | $30M | $28M | $26M | $22M | $24M | $23M | $21M | $25M | $19M | $19M | $18M | $14M | $12M | |
| Common Stock | $13.0K | $11.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | $800M | $789M | $599M | $597M | $595M | $528M | $526M | $524M | $522M | $520M | $436M | $434M | $432M | $430M | $428M | $370M | |
| Retained Earnings | $-675M | $-641M | $-609M | $-589M | $-564M | $-537M | $-511M | $-486M | $-462M | $-440M | $-411M | $-389M | $-367M | $-343M | $-317M | $-261M | |
| AOCI | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $-386.0K | |
| Stockholders' Equity | $128M | $151M | $-7M | $10M | $34M | $-5M | $18M | $41M | $64M | $84M | $29M | $48M | $69M | $91M | $114M | $109M | |
| Liabilities + Equity | $159M | $190M | $24M | $41M | $61M | $21M | $41M | $65M | $86M | $104M | $54M | $67M | $89M | $109M | $128M | $121M | |
| Shares Outstanding | 13,644,467 | 13,621,483 | 90,150,869 | 98,650,590 | 98,650,590 | 90,150,869 | 90,150,869 | 90,079,016 | 90,079,016 | 90,079,016 | 45,177,730 | 44,595,383 | 44,488,371 | 44,403,838 | 39,307,286 | 30,564,995 |
Flux de trésorerie 11
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $33.0K | $42.0K | $40.0K | $43.0K | $43.0K | $35.0K | $42.0K | $31.0K | $26.0K | $23.0K | $34.0K | $22.0K | $32.0K | $19.0K | $17.0K | |
| Stock-based Comp | $7M | $4M | $1M | $4M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $11M | · | · | · | $2M | · | · | · | $3M | · | · | · | $4M | · | · | |
| Operating Cash Flow | $-31M | $-17M | $-19M | $-20M | $-25M | $-22M | $-23M | $-21M | $-17M | $-24M | $-14M | $-17M | $-20M | $-20M | $-15M | $-14M | |
| CapEx | $249.0K | $2.0K | $11.0K | $67.0K | $36.0K | $47.0K | $3.0K | $50.0K | $180.0K | $31.0K | $165.0K | $44.0K | $21.0K | $104.0K | $-1.0K | $73.0K | |
| Investing Cash Flow | $-249.0K | $-2.0K | $-11.0K | $-67.0K | $-36.0K | $-47.0K | $-3.0K | $-50.0K | $-180.0K | $-31.0K | $-165.0K | $-44.0K | $4M | $5M | $-10M | $-73.0K | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $191.0K | $571.0K | $282.0K | $0 | $0 | · | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $191.0K | · | · | · | $0 | · | · | |
| Financing Cash Flow | $118.0K | $189M | $59.0K | $0 | $66M | $0 | $77.0K | $0 | $0 | $74M | $604.0K | $282.0K | $96.0K | $51.0K | $56M | $0 | |
| Net Change in Cash | $-32M | $171M | $-20M | $-20M | $41M | $-21M | $-23M | $-21M | $-18M | $51M | $-13M | $-18M | $-15M | $-14M | $34M | $-15M | |
| Free Cash Flow | · | $-17M | · | · | · | $-22M | · | · | · | $-24M | · | · | · | $-20M | · | · |
Rentabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -30.9% | -31.0% | · | -48.5% | -36.3% | -40.9% | · | -37.0% | -24.4% | -27.8% | · | -24.2% | -21.1% | -19.5% | · | -15.3% | |
| ROE | -42.2% | -44.7% | · | -98.9% | -55.0% | -65.1% | · | -54.4% | -32.2% | -33.9% | · | -29.0% | -24.3% | -22.1% | · | -16.7% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.9 | · | 1.3 | 2.2 | 0.7 | · | 2.7 | 3.7 | 5.1 | · | 3.7 | 4.7 | 6.5 | · | 7.5 | |
| Quick Ratio | 5.0 | 4.9 | · | 1.2 | 2.0 | 0.6 | · | 2.5 | 3.5 | 4.8 | · | 3.4 | 4.2 | 5.7 | · | 6.3 |
Valorisation (TTM) 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-119M | $-110M | · | $-102M | $-98M | $-101M | · | $-98M | $-98M | $-102M | · | $-93M | $-92M | $-89M | · | $-85M | |
| Market Cap | $210M | $15M | · | $87M | $69M | $98M | · | $149M | $100M | $119M | · | $66M | $112M | $66M | · | $97M | |
| P/E | -3.8 | -0.3 | · | -1.1 | -0.8 | -1.1 | · | -1.3 | -0.7 | -0.7 | · | -0.6 | -1.0 | -0.5 | · | -1.1 | |
| P/B | 1.6 | 0.1 | · | 8.3 | 2.0 | -18.6 | · | 3.6 | 1.6 | 1.4 | · | 1.4 | 1.6 | 0.7 | · | 0.9 | |
| P / Tangible Book | 1.6 | 0.1 | · | 8.3 | 2.0 | · | · | 3.6 | 1.6 | 1.4 | · | 1.4 | 1.6 | 0.7 | · | 1.3 | |
| P / Cash Flow | · | -0.9 | · | · | · | -4.5 | · | · | · | -5.0 | · | · | · | -3.4 | · | · | |
| P / FCF | · | -0.9 | · | · | · | -4.5 | · | · | · | -5.0 | · | · | · | -3.4 | · | · | |
| Earnings Yield | -26.3% | -353.1% | · | -93.0% | -128.9% | -91.7% | · | -76.4% | -140.5% | -146.2% | · | -157.8% | -100.8% | -183.2% | · | -93.7% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Résultat net | $-97M | $-101M | $-94M | $-120M | $-93M |
| BPA dilué | $-0.62 | $-1.00 | $-2.11 | $-3.78 | $-3.93 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | — | 1.8 | 2.1 | 9.6 | 9.2 |
| Ratio de liquidité réduite | — | 1.6 | 1.9 | 8.2 | 7.6 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | — | $-85M | $-71M | $-65M | $-83M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 3 déclarants · $415K total · Au 31 mars 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q1 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 34 (+25 vs T. préc.) | 18 (+9 vs T. préc.) | 20 (+1 vs T. préc.) | 8 (0 vs T. préc.) | +10.0M |
Comparé à Q4 2025. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $395 449 | 740 542 | 95,22% | Actions |
| WOLVERINE TRADING, LLC | $10 239 | 10 953 | 2,47% | Actions |
| CWM, LLC | $9 593 | 8 642 | 2,31% | Actions |
Initiés de la société 38 initiés · 8 dirigeants · 12 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Erik Lundgren | Chief Executive Officer | 22 mai 2026 A | — | 0 | 0 | $0 |
| Glenn Whaley | Chief Financial Officer | 29 juin 2026 A | 95 510 | 0 | 0 | $0 |
| Sanjay S Patel | Chief Financial Officer | 22 juillet 2019 A | — | 0 | 0 | $0 |
| Jason Tardio | President and COO | 29 juin 2026 A | 12 512 | 0 | 0 | $0 |
| Manfred Groeppel | Chief Operating Officer | 1 mars 2021 A | 278 830 | 0 | 0 | $0 |
| Michael A. Panzara | Chief Medical Officer | 24 avril 2026 A | — | 0 | 0 | $0 |
| Andreas Muehler | Chief Medical Officer | 16 juillet 2025 A | 297 986 | 0 | 0 | $0 |
| Duane Nash | Executive Chairman | 16 juillet 2025 A | 36 032 | 0 | 0 | $0 |
| Simona Skerjanec | Administrateur | 5 juillet 2026 A | — | 0 | 0 | $0 |
| Richard Alan Rudick | Administrateur | 5 juillet 2026 A | 230 375 | 0 | 0 | $0 |
| Joerg Neermann | Administrateur | 5 juillet 2026 A | 200 000 | 0 | 0 | $0 |
| Jon Congleton | Administrateur | 5 juillet 2026 A | — | 0 | 0 | $0 |
| Barclay A Phillips | Administrateur | 5 juillet 2026 A | — | 0 | 0 | $0 |
| Daniel Vitt | Administrateur | 29 juin 2026 A | 29 000 | 0 | 0 | $0 |
| Michael W Bonney | Administrateur | 29 juin 2026 A | — | 0 | 0 | $0 |
| Tamar D Howson | Administrateur | 29 juin 2026 A | — | 0 | 0 | $0 |
| Monika Maria Toernsen | Administrateur | 5 juin 2025 A | — | 0 | 0 | $0 |
| Jan Van Den Bossche | Administrateur | 15 juin 2022 A | — | 0 | 0 | $0 |
| Vincent Ossipow | Administrateur | 15 juin 2022 A | — | 0 | 0 | $0 |
| Elena Ridloff | — | 6 août 2026 A | — | 0 | 0 | $0 |
| Michael V. Swanson | — | 11 janvier 2019 A | — | 0 | 0 | $0 |
| Robert A. Ashley | — | 11 janvier 2019 A | 2 000 | 0 | 0 | $0 |
| Russell J. Cox | — | 11 janvier 2019 A | — | 0 | 0 | $0 |
| John Michael Dunn | — | 11 janvier 2019 A | 11 885 | 0 | 0 | $0 |
| Errol R. Halperin | — | 25 septembre 2018 S | 0 | 0 | 0 | $0 |
| Jean Jacques Bienaime | — | 24 septembre 2018 S | 18 500 | 0 | 0 | $0 |
| Douglas Evan Godshall | — | 19 septembre 2018 S | 0 | 0 | 0 | $0 |
| Satter Muneer A | — | 17 septembre 2018 S | 0 | 0 | 0 | $0 |
| Faheem Hasnain | — | 13 septembre 2018 S | 4 500 | 0 | 0 | $0 |
| Cheryl Cohen | — | 12 septembre 2018 S | 0 | 0 | 0 | $0 |
| Aron Stern | — | 1 juillet 2018 A | 6 380 | 0 | 0 | $0 |
| Andrew Henry | — | 9 juin 2018 A | — | 0 | 0 | $0 |
| Richard M Murawski | — | 9 juin 2018 A | — | 0 | 0 | $0 |
| Michael J. Millis | — | 23 mai 2018 A | 17 680 | 0 | 0 | $0 |
| Lowell Sears | — | 23 mai 2018 A | 58 572 | 0 | 0 | $0 |
| Terence E. Winters | — | 14 juin 2017 P | 194 966 | 0 | 0 | $0 |
| Philip M Croxford | — | 23 mai 2017 A | 25 091 | 0 | 0 | $0 |
| Randolph C Steer | — | 23 mai 2017 A | 1 549 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 12 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, R. Thorvald Nagel | 20 février 2026 | 9,99% | Dépôt initial | Investissement passif | SEC |
| LSP V Coöperatieve U.A, LSP V Management B.V. ×2 dépôts | 24 février 2023 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 13 février 2023 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 15 mars 2022 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 21 septembre 2020 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 18 juin 2020 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 23 avril 2019 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 22 avril 2019 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 22 avril 2019 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 22 avril 2019 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 22 avril 2019 | — | Dépôt initial | — | SEC |
| Muneer A. Satter (2) ×3 dépôts | 18 septembre 2018 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 4 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.